Zoetis Inc Cl A (ZTS)

$117.28 -0.98 (-0.83%)
Market Cap 49.79B
Revenue (ttm) 9.47B
Net Income (ttm) 2.67B
EPS (ttm) N/A
PE Ratio 18.27
Forward PE 16.70
Profit Margin 28.23%
Debt to Equity Ratio 2.71
Volume 917,549
Avg Vol 4,309,014
Day's Range N/A - N/A
Shares Out 422.13M
Stochastic %K 89%
Beta 0.98
Analysts Sell
Price Target $151.13

Company Profile

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally. The company commercializes products primarily across companion animals comprising dogs, cats, and horses; and species, including livestock, such as cattle, swine, poultry, fish, and sheep. It also offers parasiticides,...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 973 822 7000
Address:
10 Sylvan Way, Parsippany, United States
DonCorleone77
DonCorleone77 Apr. 7 at 11:40 AM
$ELAN $IDXX $ZTS $TRUP $CHWY Attached is a page from a Piper Sandler analyst report regarding ELAN, IDXX, ZTS, TRUP and CHWY issued 4.2.26
0 · Reply
SparkyReturns
SparkyReturns Apr. 6 at 5:11 PM
$BMY Biotech tip: ICU up 12%. Market cap 14 Million TAM is 15-30 BILLION. [Read that again] SCD Device calms Cytokine Storm, 6 BDDs from FDA in variety of indications from AKI to Cardio/LVAD to respiratory to burn victims. Already has pediatric HDE approval, adult study finishing EOY. Being used by top hospitals, Mayo, Cinci Childrens, Philly.... Hospitals calling it "New Standard of Care" for severe AKI. Revenue just ramping up - inflection point. Prior FDA grant, new AREVA military grant. Zero Debt. 90% margins. Low Rollout cost. Partnerships with BP - Fresenius already in. $SNY $GSK $VRTX $ZTS
0 · Reply
IslandGuy23
IslandGuy23 Apr. 5 at 2:40 PM
$ZTS inside bar in weekly. $132 fair target
0 · Reply
T_L808
T_L808 Mar. 27 at 8:08 PM
$ZTS at this rate, I'd be surprised if this doesn't take out it's COVID low
0 · Reply
Rm586
Rm586 Mar. 25 at 3:53 PM
$VNRX $ZTS should buy this for 100 m
0 · Reply
handmedown1
handmedown1 Mar. 24 at 2:18 PM
$ZTS hot garbage
0 · Reply
IslandGuy23
IslandGuy23 Mar. 23 at 6:11 PM
$ZTS can gain on this. Multiple bottom play-has devices in this tech (SMARTBOW for cow location tracking). #Peterthiel
1 · Reply
wheresdannynow
wheresdannynow Mar. 20 at 7:22 PM
Animal health entering the mRNA phase. AI optimized vaccines + next gen delivery targeting dogs and cats is a real growth lane. $MRNA $BNTX $ZTS proving how valuable vaccine platforms can be. $BIOV advancing DPX + mRNA into companion animals = optionality.
0 · Reply
handmedown1
handmedown1 Mar. 18 at 9:40 PM
$ZTS hot garbage
1 · Reply
DonCorleone77
DonCorleone77 Mar. 17 at 4:17 PM
$ELAN $ZTS Attached is page 1 of a Stifel analyst report regarding ELAN and ZTS issued yesterday.
0 · Reply
Latest News on ZTS
Zoetis to Host Webcast and Conference Call on First Quarter 2026 Financial Results

Apr 2, 2026, 8:30 AM EDT - 5 days ago

Zoetis to Host Webcast and Conference Call on First Quarter 2026 Financial Results

Zoetis to Participate in the KeyBanc Capital Markets Healthcare Forum

Mar 12, 2026, 8:30 AM EDT - 26 days ago

Zoetis to Participate in the KeyBanc Capital Markets Healthcare Forum

Zoetis to Participate in Upcoming Investor Conferences

Mar 5, 2026, 8:30 AM EST - 4 weeks ago

Zoetis to Participate in Upcoming Investor Conferences

Zoetis to Acquire Animal Genomics Business from Neogen®, Accelerating Precision Animal Health Innovation

Mar 2, 2026, 7:00 AM EST - 5 weeks ago

Zoetis to Acquire Animal Genomics Business from Neogen®, Accelerating Precision Animal Health Innovation

Zoetis to Participate in the Bank of America Securities 2026 Animal Health Summit

Feb 24, 2026, 8:30 AM EST - 6 weeks ago

Zoetis to Participate in the Bank of America Securities 2026 Animal Health Summit

Analysts Question Zoetis' Pathway To Growth As Key Segments Slide

Feb 12, 2026, 1:24 PM EST - 7 weeks ago

Analysts Question Zoetis' Pathway To Growth As Key Segments Slide

Zoetis forecasts strong 2026 profit, revenue on steady pet‑medicine demand

Feb 12, 2026, 8:33 AM EST - 7 weeks ago

Zoetis forecasts strong 2026 profit, revenue on steady pet‑medicine demand

Zoetis Reports Fourth Quarter and Full Year 2025 Results

Feb 12, 2026, 7:00 AM EST - 7 weeks ago

Zoetis Reports Fourth Quarter and Full Year 2025 Results

Top Wall Street Forecasters Revamp Zoetis Expectations Ahead Of Q4 Earnings

Feb 12, 2026, 2:12 AM EST - 7 weeks ago

Top Wall Street Forecasters Revamp Zoetis Expectations Ahead Of Q4 Earnings

Zoetis Declares Second Quarter 2026 Dividend

Feb 5, 2026, 4:15 PM EST - 2 months ago

Zoetis Declares Second Quarter 2026 Dividend

Trade Tracker: Stephanie Link sells Eaton and buys more Zoetis, Natera

Jan 7, 2026, 1:49 PM EST - 3 months ago

Trade Tracker: Stephanie Link sells Eaton and buys more Zoetis, Natera

ETN NTRA

Zoetis to Host Webcast and Conference Call on Fourth Quarter and Full Year 2025 Financial Results

Dec 30, 2025, 8:30 AM EST - 3 months ago

Zoetis to Host Webcast and Conference Call on Fourth Quarter and Full Year 2025 Financial Results

These stocks fell hard in 2025, but analysts see as much as 65% upside for them in 2026

Dec 29, 2025, 9:59 AM EST - 3 months ago

These stocks fell hard in 2025, but analysts see as much as 65% upside for them in 2026

ACN ADBE ALGN CARR CMG CPRT EIX

Trade Tracker: Stephanie Link buys mores Zoetis

Dec 23, 2025, 4:04 PM EST - 3 months ago

Trade Tracker: Stephanie Link buys mores Zoetis

Zoetis to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Dec 18, 2025, 8:30 AM EST - 3 months ago

Zoetis to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Zoetis Announces Pricing of $1.75 Billion Convertible Senior Notes Offering

Dec 16, 2025, 1:15 AM EST - 4 months ago

Zoetis Announces Pricing of $1.75 Billion Convertible Senior Notes Offering

Zoetis Announces Proposed $1.75 Billion Convertible Senior Notes Offering

Dec 15, 2025, 7:09 AM EST - 4 months ago

Zoetis Announces Proposed $1.75 Billion Convertible Senior Notes Offering

Zoetis Declares First Quarter 2026 Dividend; Board Approves 6% Payment Increase

Dec 11, 2025, 4:15 PM EST - 4 months ago

Zoetis Declares First Quarter 2026 Dividend; Board Approves 6% Payment Increase

Zoetis Receives Health Canada Approval for Portela™(relfovetmab injection) to Alleviate Pain Associated with Osteoarthritis in Cats

Dec 5, 2025, 8:30 AM EST - 4 months ago

Zoetis Receives Health Canada Approval for Portela™(relfovetmab injection) to Alleviate Pain Associated with Osteoarthritis in Cats

Zoetis Highlights R&D Leadership and Long-Term Growth Opportunity at Innovation Webcast

Dec 2, 2025, 7:30 AM EST - 4 months ago

Zoetis Highlights R&D Leadership and Long-Term Growth Opportunity at Innovation Webcast

Zoetis Receives European Commission Marketing Authorization for Lenivia® (izenivetmab) to Reduce Pain Associated with Osteoarthritis (OA) in Dogs

Nov 26, 2025, 4:15 PM EST - 4 months ago

Zoetis Receives European Commission Marketing Authorization for Lenivia® (izenivetmab) to Reduce Pain Associated with Osteoarthritis (OA) in Dogs

Zoetis Osteoarthritis Pain Franchise Needs A Reset: Analyst

Nov 21, 2025, 12:24 PM EST - 4 months ago

Zoetis Osteoarthritis Pain Franchise Needs A Reset: Analyst

Zoetis to Participate in the Piper Sandler 37th Annual Healthcare Conference

Nov 20, 2025, 8:30 AM EST - 4 months ago

Zoetis to Participate in the Piper Sandler 37th Annual Healthcare Conference

Zoetis to Host Innovation Webcast

Nov 19, 2025, 8:30 AM EST - 4 months ago

Zoetis to Host Innovation Webcast

These stocks have been hit hard in 2025 but could surge by as much as 57% from here

Nov 17, 2025, 11:24 AM EST - 5 months ago

These stocks have been hit hard in 2025 but could surge by as much as 57% from here

ADBE ALGN BLDR CARR CMG CPRT CRM

Zoetis: A High-Quality Compounder Now On Sale?

Nov 14, 2025, 11:35 AM EST - 5 months ago

Zoetis: A High-Quality Compounder Now On Sale?

Zoetis Stock Outlook Clouded By Rising Competitive Pressures

Nov 4, 2025, 1:15 PM EST - 5 months ago

Zoetis Stock Outlook Clouded By Rising Competitive Pressures

This Animal Health Stock Tanks on Earnings. Pig and Chicken Medication Revenue Slumps.

Nov 4, 2025, 8:59 AM EST - 5 months ago

This Animal Health Stock Tanks on Earnings. Pig and Chicken Medication Revenue Slumps.

Zoetis trims annual revenue forecast on muted demand for animal treatments, shares slide

Nov 4, 2025, 7:44 AM EST - 5 months ago

Zoetis trims annual revenue forecast on muted demand for animal treatments, shares slide

Zoetis Announces Third Quarter 2025 Results

Nov 4, 2025, 7:00 AM EST - 5 months ago

Zoetis Announces Third Quarter 2025 Results

Zoetis Announces Retirement of Rob Polzer at the End of 2025 and the Appointment of Kevin Esch as President of Research & Development for World Leader in Animal Health Beginning in 2026

Nov 3, 2025, 4:15 PM EST - 5 months ago

Zoetis Announces Retirement of Rob Polzer at the End of 2025 and the Appointment of Kevin Esch as President of Research & Development for World Leader in Animal Health Beginning in 2026

Buy Zoetis Stock Today?

Oct 31, 2025, 10:10 AM EDT - 5 months ago

Buy Zoetis Stock Today?

Zoetis Receives European Commission Marketing Authorization for Portela® (relfovetmab) to Alleviate Pain Associated with Osteoarthritis in Cats

Oct 29, 2025, 8:30 AM EDT - 5 months ago

Zoetis Receives European Commission Marketing Authorization for Portela® (relfovetmab) to Alleviate Pain Associated with Osteoarthritis in Cats

Zoetis Appoints Stephanie Tilenius to its Board of Directors

Oct 28, 2025, 8:30 AM EDT - 5 months ago

Zoetis Appoints Stephanie Tilenius to its Board of Directors

Zoetis Stock: Outlook Remains Muted

Oct 21, 2025, 6:48 AM EDT - 6 months ago

Zoetis Stock: Outlook Remains Muted

Zoetis Announces Health Canada Approval of Lenivia® (izenivetmab injection) for Alleviation of Osteoarthritis (OA) Pain in Dogs

Oct 15, 2025, 7:00 AM EDT - 6 months ago

Zoetis Announces Health Canada Approval of Lenivia® (izenivetmab injection) for Alleviation of Osteoarthritis (OA) Pain in Dogs

Zoetis Receives Positive Opinion from CVMP for Lenivia® (izenivetmab) to Reduce Pain Associated with Osteoarthritis (OA) in Dogs

Oct 10, 2025, 4:15 PM EDT - 6 months ago

Zoetis Receives Positive Opinion from CVMP for Lenivia® (izenivetmab) to Reduce Pain Associated with Osteoarthritis (OA) in Dogs

Zoetis Declares Fourth Quarter 2025 Dividend

Oct 9, 2025, 4:15 PM EDT - 6 months ago

Zoetis Declares Fourth Quarter 2025 Dividend

Zoetis Receives Conditional Approval for Dectomax®-CA1 Injectable for the Prevention and Treatment of New World Screwworm Myiasis in Cattle

Sep 30, 2025, 4:15 PM EDT - 6 months ago

Zoetis Receives Conditional Approval for Dectomax®-CA1 Injectable for the Prevention and Treatment of New World Screwworm Myiasis in Cattle

Zoetis to Host Webcast and Conference Call on Third Quarter 2025 Financial Results

Sep 23, 2025, 8:30 AM EDT - 7 months ago

Zoetis to Host Webcast and Conference Call on Third Quarter 2025 Financial Results

Zoetis Receives Positive Opinion from CVMP for Portela® (relfovetmab) to Alleviate Pain Associated with Osteoarthritis in Cats

Sep 12, 2025, 12:09 PM EDT - 7 months ago

Zoetis Receives Positive Opinion from CVMP for Portela® (relfovetmab) to Alleviate Pain Associated with Osteoarthritis in Cats

Zoetis to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

Aug 27, 2025, 8:30 AM EDT - 7 months ago

Zoetis to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

Zoetis Announces Pricing of $1.85 Billion of Senior Notes

Aug 11, 2025, 6:48 PM EDT - 8 months ago

Zoetis Announces Pricing of $1.85 Billion of Senior Notes

Zoetis CEO: It's unclear if animal health will be a part of pharmaceutical tariffs

Aug 5, 2025, 5:14 PM EDT - 8 months ago

Zoetis CEO: It's unclear if animal health will be a part of pharmaceutical tariffs

Zoetis Lifts Outlook As Companion Animal Portfolio Offsets Librela Decline

Aug 5, 2025, 10:50 AM EDT - 8 months ago

Zoetis Lifts Outlook As Companion Animal Portfolio Offsets Librela Decline

Animal healthcare firm Zoetis raises annual forecast on strong pet product demand

Aug 5, 2025, 8:24 AM EDT - 8 months ago

Animal healthcare firm Zoetis raises annual forecast on strong pet product demand

Zoetis Announces Second Quarter 2025 Results, Raises Full Year 2025 Outlook

Aug 5, 2025, 7:00 AM EDT - 8 months ago

Zoetis Announces Second Quarter 2025 Results, Raises Full Year 2025 Outlook

Zoetis to Host Webcast and Conference Call on Second Quarter 2025 Financial Results

Jul 1, 2025, 8:30 AM EDT - 10 months ago

Zoetis to Host Webcast and Conference Call on Second Quarter 2025 Financial Results

Zoetis Stock Is Falling. Why the Animal-Health Company Was Downgraded.

Jun 18, 2025, 12:46 PM EDT - 10 months ago

Zoetis Stock Is Falling. Why the Animal-Health Company Was Downgraded.

Top Stock Movers Now: Jabil, Oracle, Zoetis, and More

Jun 18, 2025, 12:01 PM EDT - 10 months ago

Top Stock Movers Now: Jabil, Oracle, Zoetis, and More

JBL ORCL

DonCorleone77
DonCorleone77 Apr. 7 at 11:40 AM
$ELAN $IDXX $ZTS $TRUP $CHWY Attached is a page from a Piper Sandler analyst report regarding ELAN, IDXX, ZTS, TRUP and CHWY issued 4.2.26
0 · Reply
SparkyReturns
SparkyReturns Apr. 6 at 5:11 PM
$BMY Biotech tip: ICU up 12%. Market cap 14 Million TAM is 15-30 BILLION. [Read that again] SCD Device calms Cytokine Storm, 6 BDDs from FDA in variety of indications from AKI to Cardio/LVAD to respiratory to burn victims. Already has pediatric HDE approval, adult study finishing EOY. Being used by top hospitals, Mayo, Cinci Childrens, Philly.... Hospitals calling it "New Standard of Care" for severe AKI. Revenue just ramping up - inflection point. Prior FDA grant, new AREVA military grant. Zero Debt. 90% margins. Low Rollout cost. Partnerships with BP - Fresenius already in. $SNY $GSK $VRTX $ZTS
0 · Reply
IslandGuy23
IslandGuy23 Apr. 5 at 2:40 PM
$ZTS inside bar in weekly. $132 fair target
0 · Reply
T_L808
T_L808 Mar. 27 at 8:08 PM
$ZTS at this rate, I'd be surprised if this doesn't take out it's COVID low
0 · Reply
Rm586
Rm586 Mar. 25 at 3:53 PM
$VNRX $ZTS should buy this for 100 m
0 · Reply
handmedown1
handmedown1 Mar. 24 at 2:18 PM
$ZTS hot garbage
0 · Reply
IslandGuy23
IslandGuy23 Mar. 23 at 6:11 PM
$ZTS can gain on this. Multiple bottom play-has devices in this tech (SMARTBOW for cow location tracking). #Peterthiel
1 · Reply
wheresdannynow
wheresdannynow Mar. 20 at 7:22 PM
Animal health entering the mRNA phase. AI optimized vaccines + next gen delivery targeting dogs and cats is a real growth lane. $MRNA $BNTX $ZTS proving how valuable vaccine platforms can be. $BIOV advancing DPX + mRNA into companion animals = optionality.
0 · Reply
handmedown1
handmedown1 Mar. 18 at 9:40 PM
$ZTS hot garbage
1 · Reply
DonCorleone77
DonCorleone77 Mar. 17 at 4:17 PM
$ELAN $ZTS Attached is page 1 of a Stifel analyst report regarding ELAN and ZTS issued yesterday.
0 · Reply
handmedown1
handmedown1 Mar. 11 at 7:34 PM
$ZTS garbage
0 · Reply
Bazzzigar
Bazzzigar Mar. 11 at 4:14 PM
$ZTS HIMS
0 · Reply
TalkMarkets
TalkMarkets Mar. 4 at 2:25 PM
8 Stocks Trading At Their 52-Week Low $BAM $CRM $TRI $UNH $ZTS https://talkmarkets.com/article/8-stocks-trading-at-their-52-week-low-1772634332
0 · Reply
Estimize
Estimize Mar. 2 at 3:03 PM
Wall St is expecting 1.61 EPS for $ZTS Q1 [Reporting 04/30 BMO] http://www.estimize.com/intro/zts?chart=historical&metric_name=eps&utm_cont
0 · Reply
topstockalerts
topstockalerts Mar. 2 at 1:41 PM
Zoetis Inc. agreed to acquire the animal genomics business of Neogen Corporation for $160 million in cash, expanding its capabilities in precision animal health. The acquisition will provide Zoetis with advanced genetic testing technologies and data analytics tools designed to improve the prediction of health outcomes and enable more tailored treatment and breeding decisions for livestock and companion animals. The genomics unit serves customers in more than 120 countries and operates five laboratories across the U.S., Brazil, Australia, China, and the U.K., along with an office in Canada. Zoetis said the transaction is expected to close in the second half of calendar 2026, subject to customary conditions. The company’s shares have risen about 4.2% in 2025. $ZTS $NEOG
0 · Reply
MyChicago
MyChicago Feb. 25 at 6:09 PM
$ZOMDF $WOOF $ZTS $HOOD $ELAN
0 · Reply
SW6
SW6 Feb. 18 at 8:59 PM
$ZTS
0 · Reply
Ripera
Ripera Feb. 17 at 2:44 PM
$ZTS holding above 124.15 50DMA with EPS 6.02, I’m long for a trend crawl
0 · Reply
ZacksResearch
ZacksResearch Feb. 12 at 3:53 PM
$ZTS posts a solid Q4 earnings beat — what's driving the gains? Zoetis delivered Q4 adjusted EPS of $1.48, topping the Zacks Consensus Estimate of $1.40, with total revenues up 3% in the reported quarter to $2.39B. Revenues in the International segment increased 8% year over year on a reported basis, driven by strength in companion animal sales. Discover why ZTS is rallying post-earnings 👉 https://www.zacks.com/stock/news/2862520/zoetis-stock-gains-after-q4-earnings-revenues-beat-estimates?cid=sm-stocktwits-2-2862520-body-33308&ADID=SYND_STOCKTWITS_TWEET_2_2862520_BODY_33308
0 · Reply
AStrokeOfLuck
AStrokeOfLuck Feb. 12 at 3:36 PM
$ZTS
0 · Reply
ZacksResearch
ZacksResearch Feb. 12 at 2:53 PM
$ZTS just delivered the kind of quarter bulls love Zoetis topped Q4 earnings and revenue estimates, sending the stock higher, as strong international growth and upbeat 2026 guidance helped offset softness in the U.S. That’s resilience with a forward-looking tailwind. Does this momentum have legs into 2026? Get the full breakdown here 👉 https://www.zacks.com/stock/news/2862520/zoetis-stock-gains-after-q4-earnings-revenues-beat-estimates?cid=sm-stocktwits-2-2862520-teaser-33286&ADID=SYND_STOCKTWITS_TWEET_2_2862520_TEASER_33286
0 · Reply